NTRA Natera, Inc.
Nasdaq · SEC CIK 1604821 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $376.04M 134 sales by 12 insiders
- Filings on record
- 782 since 2021-07-07, latest 2026-09-18 21:35
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Rabinowitz Matthew | EXECUTIVE COB, Dir | — | $124.05M |
| Chapman Steven Leonard | CEO AND Pres, Dir | — | $93.95M |
| BOTHA ROELOF | Dir | — | $34.89M |
| RABINOWITZ DANIEL | SEC. AND CLO | — | $23.83M |
| Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | — | $22.88M |
| Sheena Jonathan | Dir, CO-FOUNDER | — | $22.83M |
| Brophy Michael Burkes | CFO | — | $22.14M |
| ROSENMAN HERM | Dir | — | $15.14M |
| Fesko John | Pres, CHIEF BUS. Off | — | $9.35M |
| Baynes Roy D. | Dir | — | $2.81M |
Transactions 1,058
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | 2026-03-09 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | — | +1,774 | 151.8K | +1% | — | |
| D | 2026-03-10 | 2026-03-06 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | $19.68 | +5,598 | 241.7K | +2% | +$110.2K |
| DM | 2026-03-10 | 2026-03-06 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $196.08 | -8,398 | 241.3K | -3% | -$1.65M |
| M | 2026-03-03 | 2026-03-02 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $200.02 | -3,950 | 156.6K | -2% | -$790.1K |
| 2026-03-03 | 2026-02-27 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | A - Grant | — | +37.4K | 160.6K | +30% | — | |
| 2026-03-03 | 2026-02-27 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | A - Grant | — | +29.9K | 2.31M | +1% | — | |
| 2026-03-03 | 2026-02-27 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | A - Grant | — | +12.3K | 236.1K | +5% | — | |
| M | 2026-03-03 | 2026-03-02 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $200.23 | -3,070 | 262.4K | -1% | -$614.7K |
| 2026-03-03 | 2026-02-27 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | A - Grant | — | +2,103 | 265.3K | +0.8% | — | |
| 2026-03-03 | 2026-02-27 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | — | +10.1K | 188.1K | +6% | — | |
| 2026-03-03 | 2026-02-27 | NTRA | Brophy Michael Burkes | CFO | A - Grant | — | +10.1K | 62.2K | +19% | — | |
| DM | 2026-03-03 | 2026-03-02 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale+OE | $199.85 | -3,000 | 150.5K | -2% | -$599.5K |
| D | 2026-03-03 | 2026-02-27 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | — | +10.1K | 147.9K | +7% | — |
| D | 2026-03-03 | 2026-03-02 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | M - OptEx | $9.59 | +5,125 | 153.0K | +3% | +$49.1K |
| M | 2026-02-04 | 2026-02-02+ | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $231.20 | -4,639 | 137.8K | -3% | -$1.07M |
| M | 2026-02-04 | 2026-02-03 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $231.02 | -3,594 | 178.1K | -2% | -$830.3K |
| 2026-02-04 | 2026-02-03 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $230.77 | -1,334 | 223.8K | -0.6% | -$307.8K | |
| 2026-02-04 | 2026-02-03 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $230.77 | -435 | 263.2K | -0.2% | -$100.4K | |
| M | 2026-02-04 | 2026-02-02+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $230.72 | -90.0K | 164.7K | -35% | -$20.77M |
| M | 2026-02-04 | 2026-02-03 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $227.83 | -6,939 | 52.1K | -12% | -$1.58M |
| 2026-02-03 | 2026-01-30 | NTRA | Williams Brinkley Ruth | Dir | A - Grant | — | +73 | 5,389 | +1% | — | |
| 2026-02-03 | 2026-01-30 | NTRA | BOTHA ROELOF | Dir | A - Grant | — | +112 | 2,540 | +5% | — | |
| 2026-02-03 | 2026-01-30 | NTRA | Bertagnolli Monica | Dir | A - Grant | — | +70 | 5,291 | +1% | — | |
| 2026-02-03 | 2026-01-30 | NTRA | ROSENMAN HERM | Dir | A - Grant | — | +99 | 20.4K | +0.5% | — | |
| 2026-02-03 | 2026-01-30 | NTRA | Baynes Roy D. | Dir | A - Grant | — | +70 | 18.4K | +0.4% | — | |
| 2026-02-03 | 2026-01-30 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | — | +6,135 | 181.7K | +3% | — | |
| 2026-02-03 | 2026-01-30 | NTRA | Marcus Gail Boxer | Dir | A - Grant | — | +91 | 5,853 | +2% | — | |
| 2026-02-03 | 2026-01-30 | NTRA | Chapman Rowan E | Dir | A - Grant | — | +97 | 5,874 | +2% | — | |
| M | 2026-01-29 | 2026-01-27+ | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $238.97 | -2,213 | 143.7K | -2% | -$528.8K |
| M | 2026-01-29 | 2026-01-27+ | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $238.97 | -1,712 | 175.5K | -1.0% | -$409.1K |
| M | 2026-01-29 | 2026-01-27+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $239.39 | -482 | 263.8K | -0.2% | -$115.4K |
| M | 2026-01-29 | 2026-01-27+ | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $239.01 | -1,886 | 225.1K | -0.8% | -$450.8K |
| M | 2026-01-29 | 2026-01-27+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $235.38 | -5,064 | 59.9K | -8% | -$1.19M |
| M | 2026-01-29 | 2026-01-27+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $238.78 | -5,970 | 213.2K | -3% | -$1.43M |
| MI | 2026-01-27 | 2026-01-23 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $243.94 | -1,500 | 21.8K | -6% | -$365.9K |
| M | 2026-01-22 | 2026-01-20+ | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $234.74 | -23.5K | 144.7K | -14% | -$5.52M |
| M | 2026-01-22 | 2026-01-20+ | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $234.74 | -18.1K | 177.3K | -9% | -$4.26M |
| DM | 2026-01-22 | 2026-01-20+ | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $234.75 | -19.7K | 226.6K | -8% | -$4.62M |
| D | 2026-01-22 | 2026-01-20 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +856 | 227.5K | +0.4% | — |
| DM | 2026-01-22 | 2026-01-20+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $234.60 | -6,144 | 267.1K | -2% | -$1.44M |
| D | 2026-01-22 | 2026-01-20 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +191 | 267.2K | +0.1% | — |
| DM | 2026-01-22 | 2026-01-20+ | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $239.49 | -61.1K | 64.1K | -49% | -$14.64M |
| D | 2026-01-22 | 2026-01-20 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,522 | 101.3K | +2% | — |
| D | 2026-01-22 | 2026-01-20 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +3,386 | 220.7K | +2% | — |
| DM | 2026-01-22 | 2026-01-20+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $234.75 | -73.5K | 219.2K | -25% | -$17.26M |
| 2026-01-16 | 2026-01-14 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | $0.00 | +44.7K | 195.4K | +30% | $0 | |
| 2026-01-16 | 2026-01-14 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | A - Grant | $0.00 | +7,450 | 270.0K | +3% | $0 | |
| 2026-01-16 | 2026-01-14 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | A - Grant | $0.00 | +152.7K | 289.3K | +112% | $0 | |
| 2026-01-16 | 2026-01-14 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | A - Grant | $0.00 | +37.2K | 245.8K | +18% | $0 | |
| 2026-01-16 | 2026-01-14 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | $0.00 | +44.7K | 168.2K | +36% | $0 | |
| 2026-01-16 | 2026-01-14 | NTRA | Brophy Michael Burkes | CFO | A - Grant | $0.00 | +59.6K | 123.7K | +93% | $0 | |
| M | 2026-01-06 | 2026-01-02 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $228.95 | -2,951 | 125.2K | -2% | -$675.6K |
| D | 2026-01-06 | 2026-01-05 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | $9.59 | +39.6K | 262.6K | +18% | +$379.9K |
| M | 2026-01-06 | 2026-01-02 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $229.08 | -3,848 | 136.6K | -3% | -$881.5K |
| MI | 2025-12-22 | 2025-12-19 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $225.94 | -1,500 | 22.5K | -6% | -$338.9K |
| 2025-12-17 | 2025-12-15 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | G - Gift | $0.00 | -1,060 | 226.0K | -0.5% | $0 | |
| M | 2025-12-17 | 2025-12-17 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $227.01 | -3,070 | 224.4K | -1% | -$696.9K |
| DM | 2025-12-16 | 2025-12-12+ | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | G - Gift | $0.00 | -295 | 126.5K | -0.2% | $0 |
| D | 2025-12-16 | 2025-12-12 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale+OE | $230.76 | -4,692 | 113.1K | -4% | -$1.08M |
| DM | 2025-12-16 | 2025-12-12 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | M - OptEx | $9.59 | +22.4K | 117.8K | +23% | +$214.6K |
| M | 2025-12-16 | 2025-12-12 | NTRA | ROSENMAN HERM | Dir | S - Sale | $227.42 | -48.4K | 20.3K | -70% | -$11.01M |
| 2025-12-16 | 2025-10-31 | NTRA | ROSENMAN HERM | Dir | A - Grant | — | +132 | 68.8K | +0.2% | — | |
| D | 2025-12-11 | 2025-12-09 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | $9.29 | +4,436 | 227.1K | +2% | +$41.2K |
| DM | 2025-12-09 | 2025-12-05 | NTRA | Chapman Rowan E | Dir | S - Sale+OE | $243.11 | -4,366 | 5,777 | -43% | -$1.06M |
| D | 2025-12-09 | 2025-12-05 | NTRA | Chapman Rowan E | Dir | M - OptEx | $32.15 | +4,000 | 10.1K | +65% | +$128.6K |
| D | 2025-12-08 | 2025-12-04 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | $19.68 | +6,902 | 208.6K | +3% | +$135.8K |
| M | 2025-12-03 | 2025-12-01 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $238.15 | -3,000 | 109.1K | -3% | -$714.5K |
| M | 2025-12-03 | 2025-12-01 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $238.07 | -4,400 | 140.4K | -3% | -$1.05M |
| MI | 2025-11-26 | 2025-11-24 | NTRA | BOTHA ROELOF | Dir | S - Sale | $236.12 | -75.0K | 1.20M | -6% | -$17.71M |
| DM | 2025-11-21 | 2025-11-19+ | NTRA | Baynes Roy D. | Dir | S - Sale+OE | $219.85 | -12.8K | 24.8K | -34% | -$2.81M |
| DM | 2025-11-21 | 2025-11-19+ | NTRA | Baynes Roy D. | Dir | M - OptEx | $41.07 | +12.8K | 19.0K | +207% | +$524.9K |
| MI | 2025-11-21 | 2025-11-21 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $230.01 | -4,000 | 23.3K | -15% | -$920.0K |
| 2025-11-21 | 2025-11-20 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $225.08 | -10.0K | 222.7K | -4% | -$2.25M | |
| M | 2025-11-12 | 2025-11-07 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $192.56 | -3,070 | 233.5K | -1% | -$591.2K |
| MI | 2025-11-12 | 2025-11-11 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $207.96 | -1,500 | 25.3K | -6% | -$311.9K |
| 2025-11-04 | 2025-10-31 | NTRA | Baynes Roy D. | Dir | A - Grant | — | +93 | 18.4K | +0.5% | — | |
| 2025-11-04 | 2025-10-31 | NTRA | Williams Brinkley Ruth | Dir | A - Grant | — | +97 | 5,316 | +2% | — | |
| MI | 2025-11-04 | 2025-11-03 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $200.07 | -4,000 | 26.0K | -13% | -$800.3K |
| 2025-11-04 | 2025-10-31 | NTRA | Chapman Rowan E | Dir | A - Grant | — | +128 | 6,143 | +2% | — | |
| M | 2025-11-04 | 2025-11-04 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $200.51 | -22.9K | 2.29M | -1.0% | -$4.59M |
| 2025-11-04 | 2025-11-03 | NTRA | Marcus Gail Boxer | Dir | S - Sale | $198.71 | -122 | 5,762 | -2% | -$24.2K | |
| 2025-11-04 | 2025-10-31 | NTRA | Marcus Gail Boxer | Dir | A - Grant | — | +121 | 5,884 | +2% | — | |
| 2025-11-04 | 2025-10-31 | NTRA | BOTHA ROELOF | Dir | A - Grant | — | +149 | 6,839 | +2% | — | |
| M | 2025-11-04 | 2025-11-03 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $198.60 | -3,000 | 113.6K | -3% | -$595.8K |
| 2025-11-04 | 2025-10-31 | NTRA | Bertagnolli Monica | Dir | A - Grant | — | +93 | 5,221 | +2% | — | |
| 2025-11-03 | 2025-11-03 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $200.00 | -17.1K | 2.30M | -0.7% | -$3.42M | |
| DM | 2025-11-03 | 2025-11-03 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | $116.02 | +155.7K | 151.9K | New | +$18.06M |
| DM | 2025-11-03 | 2025-11-03 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $199.96 | -160.7K | 303.3K | -35% | -$32.13M |
| M | 2025-10-29 | 2025-10-27+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $191.79 | -6,015 | 149.8K | -4% | -$1.15M |
| M | 2025-10-29 | 2025-10-27+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $191.15 | -5,063 | 66.6K | -7% | -$967.8K |
| M | 2025-10-29 | 2025-10-27+ | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $191.85 | -1,709 | 151.6K | -1% | -$327.9K |
| M | 2025-10-29 | 2025-10-27+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $191.98 | -479 | 235.7K | -0.2% | -$92.0K |
| M | 2025-10-29 | 2025-10-27+ | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $191.85 | -2,206 | 116.3K | -2% | -$423.2K |
| M | 2025-10-29 | 2025-10-27+ | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $191.86 | -1,993 | 201.7K | -1.0% | -$382.4K |
| D | 2025-10-24 | 2025-10-22 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,250 | 70.4K | +2% | — |
| DM | 2025-10-24 | 2025-10-22+ | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $190.30 | -2,170 | 69.9K | -3% | -$413.0K |
| D | 2025-10-22 | 2025-10-20 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +190 | 236.3K | +0.1% | — |
| D | 2025-10-22 | 2025-10-21 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $187.95 | -93 | 236.2K | -0.0% | -$17.5K |
| D | 2025-10-22 | 2025-10-21 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $187.95 | -602 | 70.1K | -0.9% | -$113.1K |
| D | 2025-10-22 | 2025-10-20 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,522 | 70.7K | +2% | — |
Purchase Sale Sale after option exercise All abbreviations